CD73 Regulates Stemness and Epithelial-Mesenchymal Transition in Ovarian Cancer-Initiating Cells
Open Access
- 15 March 2018
- journal article
- research article
- Published by Elsevier BV in Stem Cell Reports
- Vol. 10 (4), 1412-1425
- https://doi.org/10.1016/j.stemcr.2018.02.009
Abstract
No abstract availableKeywords
Funding Information
- Associazione Italiana Ricerca sul Cancro (AIRC IG-14622)
- Association for International Cancer Research (AICR 10-0091)
- Fondazione Istituto Europeo di Oncologia
This publication has 59 references indexed in Scilit:
- Association between theBRCA2rs144848 polymorphism and cancer susceptibility: a meta-analysisOncotarget, 2017
- A preliminary study of the role of extracellular -5′- nucleotidase in breast cancer stem cells and epithelial-mesenchymal transitionIn Vitro Cellular & Developmental Biology – Animal, 2016
- Immunosuppressive activities of adenosine in cancerCurrent Opinion in Pharmacology, 2016
- Runx2 contributes to the regenerative potential of the mammary epitheliumScientific Reports, 2015
- VAV3 Overexpressed in Cancer Stem Cells Is a Poor Prognostic Indicator in Ovarian Cancer PatientsStem Cells and Development, 2015
- Tenascin-C Protects Cancer Stem–like Cells from Immune Surveillance by Arresting T-cell ActivationCancer Research, 2015
- Functional genomics identifies five distinct molecular subtypes with clinical relevance and pathways for growth control in epithelial ovarian cancerEMBO Molecular Medicine, 2013
- Epithelial–Mesenchymal Transition in Ovarian CarcinomaFrontiers in Oncology, 2012
- CD73 has distinct roles in nonhematopoietic and hematopoietic cells to promote tumor growth in miceJCI Insight, 2011
- RNA interference of ecto-5′-nucleotidase (CD73) inhibits human breast cancer cell growth and invasionClinical & Experimental Metastasis, 2007